Fisher Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.91M | Buy |
5,059
+69
| +1% | +$52.8K | ﹤0.01% | 490 |
|
|
2025
Q4 | $3.85M | Buy |
4,990
+353
| +8% | +$240K | ﹤0.01% | 490 |
|
|
2025
Q3 | $2.61M | Buy |
4,637
+284
| +7% | +$161K | ﹤0.01% | 540 |
|
|
2025
Q2 | $2.29M | Hold |
4,353
| – | – | ﹤0.01% | 555 |
|
|
2025
Q1 | $2.76M | Sell |
4,353
-1,537
| -26% | -$1.06M | ﹤0.01% | 543 |
|
|
2024
Q4 | $4.2M | Buy |
5,890
+833
| +16% | +$699K | ﹤0.01% | 511 |
|
|
2024
Q3 | $5.32M | Sell |
5,057
-608
| -11% | -$677K | ﹤0.01% | 483 |
|
|
2024
Q2 | $5.95M | Sell |
5,665
-149
| -3% | -$144K | ﹤0.01% | 474 |
|
|
2024
Q1 | $5.6M | Buy |
5,814
+192
| +3% | +$183K | ﹤0.01% | 496 |
|
|
2023
Q4 | $4.94M | Buy |
5,622
+472
| +9% | +$389K | ﹤0.01% | 494 |
|
|
2023
Q3 | $4.24M | Sell |
5,150
-218
| -4% | -$171K | ﹤0.01% | 538 |
|
|
2023
Q2 | $3.86M | Buy |
5,368
+1,001
| +23% | +$772K | ﹤0.01% | 578 |
|
|
2023
Q1 | $3.59M | Sell |
4,367
-239
| -5% | -$180K | ﹤0.01% | 585 |
|
|
2022
Q4 | $3.32M | Sell |
4,606
-13
| -0.3% | -$9.59K | ﹤0.01% | 575 |
|
|
2022
Q3 | $3.18M | Buy |
4,619
+50
| +1% | +$31.5K | ﹤0.01% | 509 |
|
|
2022
Q2 | $2.7M | Buy |
4,569
+3
| +0.1% | +$1.95K | ﹤0.01% | 494 |
|
|
2022
Q1 | $3.19M | Sell |
4,566
-650
| -12% | -$411K | ﹤0.01% | 495 |
|
|
2021
Q4 | $3.29M | Buy |
5,216
+142
| +3% | +$87.3K | ﹤0.01% | 500 |
|
|
2021
Q3 | $3.07M | Sell |
5,074
-85
| -2% | -$52.8K | ﹤0.01% | 480 |
|
|
2021
Q2 | $2.88M | Buy |
5,159
+44
| +0.9% | +$22.3K | ﹤0.01% | 483 |
|
|
2021
Q1 | $2.42M | Sell |
5,115
-112
| -2% | -$54.5K | ﹤0.01% | 504 |
|
|
2020
Q4 | $2.52M | Sell |
5,227
-44
| -0.8% | -$23.8K | ﹤0.01% | 488 |
|
|
2020
Q3 | $2.95M | Buy |
5,271
+130
| +3% | +$78.8K | ﹤0.01% | 441 |
|
|
2020
Q2 | $3.21M | Sell |
5,141
-2
| -0% | -$1.14K | ﹤0.01% | 429 |
|
|
2020
Q1 | $2.51M | Sell |
5,143
-145
| -3% | -$59.8K | ﹤0.01% | 419 |
|
|
2019
Q4 | $1.99M | Sell |
5,288
-159
| -3% | -$53.5K | ﹤0.01% | 495 |
|
|
2019
Q3 | $1.51M | Buy |
5,447
+18
| +0.3% | +$5.33K | ﹤0.01% | 575 |
|
|
2019
Q2 | $1.7M | Sell |
5,429
-99
| -2% | -$33K | ﹤0.01% | 560 |
|
|
2019
Q1 | $2.27M | Buy |
5,528
+4,264
| +337% | +$1.76M | ﹤0.01% | 509 |
|
|
2018
Q4 | $472K | Sell |
1,264
-14
| -1% | -$5.12K | ﹤0.01% | 659 |
|
|
2018
Q3 | $516K | Sell |
1,278
-302
| -19% | -$115K | ﹤0.01% | 651 |
|
|
2018
Q2 | $545K | Buy |
1,580
+250
| +19% | +$78.2K | ﹤0.01% | 631 |
|
|
2018
Q1 | $458K | Sell |
1,330
-135
| -9% | -$47K | ﹤0.01% | 632 |
|
|
2017
Q4 | $551K | Sell |
1,465
-109
| -7% | -$44.1K | ﹤0.01% | 642 |
|
|
2017
Q3 | $704K | Buy |
1,574
+163
| +12% | +$77.6K | ﹤0.01% | 599 |
|
|
2017
Q2 | $693K | Buy |
1,411
+605
| +75% | +$265K | ﹤0.01% | 572 |
|
|
2017
Q1 | $312K | Buy |
806
+91
| +13% | +$33.7K | ﹤0.01% | 619 |
|
|
2016
Q4 | $262K | Buy |
715
+95
| +15% | +$36.1K | ﹤0.01% | 640 |
|
|
2016
Q3 | $249K | Buy |
620
+7
| +1% | +$2.81K | ﹤0.01% | 649 |
|
|
2016
Q2 | $230K | Hold |
613
| – | – | ﹤0.01% | 646 |
|
|
2016
Q1 | $249K | Sell |
613
-2
| -0.3% | -$824 | ﹤0.01% | 632 |
|
|
2015
Q4 | $334K | Buy |
615
+111
| +22% | +$60.1K | ﹤0.01% | 612 |
|
|
2015
Q3 | $234K | Sell |
504
-61
| -11% | -$32.8K | ﹤0.01% | 616 |
|
|
2015
Q2 | $288K | Buy |
565
+31
| +6% | +$15.1K | ﹤0.01% | 508 |
|
|
2015
Q1 | $241K | Buy |
534
+10
| +2% | +$4.24K | ﹤0.01% | 519 |
|
|
2014
Q4 | $215K | Sell |
524
-59
| -10% | -$23.2K | ﹤0.01% | 541 |
|
|
2014
Q3 | $210K | Buy |
+583
| New | +$195K | ﹤0.01% | 506 |
|
Other funds holding REGN
VCM
N
